Page last updated: 2024-10-29

itraconazole and Benign Neoplasms

itraconazole has been researched along with Benign Neoplasms in 3 studies

Research Excerpts

ExcerptRelevanceReference
"Particularly due to its link to cancer, small molecule Hh pathway inhibitors have been developed and the first compounds have been approved for use in Hh-driven basal cell carcinoma."2.61Inhibiting Hedgehog: An Update on Pharmacological Compounds and Targeting Strategies. ( Dempwolff, L; Diederich, WE; Galperin, I; Lauth, M, 2019)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Heretsch, P1
Tzagkaroulaki, L1
Giannis, A1
Galperin, I1
Dempwolff, L1
Diederich, WE1
Lauth, M1
Gong, Q1
Hu, J1
Wang, P1
Li, X1
Zhang, X1

Reviews

3 reviews available for itraconazole and Benign Neoplasms

ArticleYear
Modulators of the hedgehog signaling pathway.
    Bioorganic & medicinal chemistry, 2010, Sep-15, Volume: 18, Issue:18

    Topics: Antineoplastic Agents; Hedgehog Proteins; Humans; Neoplasms; Signal Transduction; Veratrum Alkaloids

2010
Inhibiting Hedgehog: An Update on Pharmacological Compounds and Targeting Strategies.
    Journal of medicinal chemistry, 2019, 09-26, Volume: 62, Issue:18

    Topics: Animals; Antineoplastic Agents; Carcinoma, Basal Cell; Drug Approval; Drug Design; Hedgehog Proteins

2019
A comprehensive review on β-lapachone: Mechanisms, structural modifications, and therapeutic potentials.
    European journal of medicinal chemistry, 2021, Jan-15, Volume: 210

    Topics: Animals; Anti-Infective Agents; Antineoplastic Agents; Drug Discovery; Humans; Naphthoquinones; Neop

2021